Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Feb;17(2):263–268. doi: 10.1128/aac.17.2.263

Effect of trimethoprim and trimethoprim-sulfamethoxazole on development of drug-resistant vaginal and fecal floras.

S J Pancoast, D M Hyams, H C Neu
PMCID: PMC283769  PMID: 7387147

Abstract

Trimethoprim-sulfamethoxazole (TMP-SMX) or trimethoprim (TMP) alone was given on a random double-blind basis to 26 young women to treat urinary tract infections. Fecal and introital aerobic bacterial floras were identified at 1, 7, 14, and 42 days to analyze changes in these floras or development of resistance to TMP or TM-SMX. Neither TMP alone nor the TMP-SMX combination administered for 2 weeks selected a resistant fecal or introital flora. In the few individuals who had strains resistant to TMP or TMP-SMX before initiation of therapy, these organisms did not persist once therapy began. Both programs effectively cleared the introitus and rectal areas of Enterobacteriaceae. Concentrations of TMP adequate to inhibit the majority of Escherichia coli strains causing urinary tract infections were found in the vaginal secretions.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acar J. F., Goldstein F., Chabbert Y. A. Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. J Infect Dis. 1973 Nov;128(Suppl):470–p. doi: 10.1093/infdis/128.supplement_3.s470. [DOI] [PubMed] [Google Scholar]
  2. Brumfitt W., Pursell R. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. Br Med J. 1972 Jun 17;2(5815):673–676. doi: 10.1136/bmj.2.5815.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Böhni E. Uber antibakterielle Eigenschaften der Kombination Trimethoprin-Sulfamethoxazol im Vergleich mit Antibiotika. Schweiz Med Wochenschr. 1969 Oct 18;99(42):1505–1510. [PubMed] [Google Scholar]
  5. Fleming M. P., Datta N., Grüneberg R. N. Trimethoprim resistance determined by R factors. Br Med J. 1972 Mar 18;1(5802):726–728. doi: 10.1136/bmj.1.5802.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jobanputra R. S., Datta N. Trimethoprim R factors in enterobacteria from clinical specimens. J Med Microbiol. 1974 May;7(2):169–177. doi: 10.1099/00222615-7-2-169. [DOI] [PubMed] [Google Scholar]
  7. Knothe H. The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut. Chemotherapy. 1973;18(5):285–296. doi: 10.1159/000221273. [DOI] [PubMed] [Google Scholar]
  8. Neu H. C., Cherubin C. E., Longo E. D., Flouton B., Winter J. Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis. 1975 Dec;132(6):617–622. doi: 10.1093/infdis/132.6.617. [DOI] [PubMed] [Google Scholar]
  9. O'Grady F., Fry I. K., McSherry A., Cattell W. R. Long-term treatment of persistent or recurrent urinary tract infection with trimethoprim-sulfamethoxazole. J Infect Dis. 1973 Nov;128(Suppl):652–p. doi: 10.1093/infdis/128.supplement_3.s652. [DOI] [PubMed] [Google Scholar]
  10. Stamey T. A., Condy M., Mihara G. Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora. N Engl J Med. 1977 Apr 7;296(14):780–783. doi: 10.1056/NEJM197704072961403. [DOI] [PubMed] [Google Scholar]
  11. Stamey T. A., Condy M. The diffusion and concentration of trimethoprim in human vaginal fluid. J Infect Dis. 1975 Mar;131(3):261–266. doi: 10.1093/infdis/131.3.261. [DOI] [PubMed] [Google Scholar]
  12. Stamey T. A., Sexton C. C. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol. 1975 Feb;113(2):214–217. doi: 10.1016/s0022-5347(17)59447-1. [DOI] [PubMed] [Google Scholar]
  13. Toivanen A., Kasan A., Sundquist H., Toivanen P. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy. 1976;22(2):97–103. doi: 10.1159/000221918. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES